rs144129296
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_033118.4(MYLK2):c.1253C>T(p.Thr418Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000737 in 1,613,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033118.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLK2 | ENST00000375985.5 | c.1253C>T | p.Thr418Ile | missense_variant | Exon 9 of 13 | 1 | NM_033118.4 | ENSP00000365152.4 | ||
MYLK2 | ENST00000375994.6 | c.1253C>T | p.Thr418Ile | missense_variant | Exon 8 of 12 | 1 | ENSP00000365162.2 | |||
MYLK2 | ENST00000468730.1 | n.191C>T | non_coding_transcript_exon_variant | Exon 2 of 6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 151960Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251340Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135856
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461786Hom.: 0 Cov.: 39 AF XY: 0.0000275 AC XY: 20AN XY: 727188
GnomAD4 genome AF: 0.000480 AC: 73AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000444 AC XY: 33AN XY: 74362
ClinVar
Submissions by phenotype
not provided Uncertain:2
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -
- -
not specified Uncertain:1Benign:1
Variant summary: MYLK2 c.1253C>T (p.Thr418Ile) results in a non-conservative amino acid change located in the protein kinase domain (IPR000719) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 251340 control chromosomes, predominantly at a frequency of 0.0014 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 56 fold of the estimated maximal expected allele frequency for a pathogenic variant in MYLK2 causing Hypertrophic Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.1253C>T in individuals affected with Hypertrophic Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Co-occurrence with another pathogenic variant has been reported ( TTR c.424G>A, p.Val142Ile), providing supporting evidence for a benign role (internal database). One ClinVar submitter (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -
The c.1253C>T (p.T418I) alteration is located in exon 9 (coding exon 8) of the MYLK2 gene. This alteration results from a C to T substitution at nucleotide position 1253, causing the threonine (T) at amino acid position 418 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
MYLK2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hypertrophic cardiomyopathy 1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at